New heart balloon shows promise in artery opening trial

NCT ID NCT05509296

Completed Disease control Sponsor: Sino Medical Sciences Technology Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new balloon catheter called SINOMED CBC for treating narrowed coronary arteries. It involved 136 patients with stable or unstable angina or evidence of heart muscle ischemia. The device was compared to a standard balloon catheter to see if it was as safe and effective at opening blockages during angioplasty.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cutting balloon catheter (SINOMED CBC)
What this could lead to: If successful, this device could offer a safe and effective alternative for opening blocked heart arteries during angioplasty.
What could go wrong: This is a small, completed non-inferiority trial, so it only shows the device is not worse than the standard. Long-term benefits or risks are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary restenosis coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY STENOSIS CORONARY STENOSIS IN STENT RESTENOSIS

Contacts and locations

Locations

Kaifeng Central Hospital

Kaifeng, China
Peking University First Hospital

Beijing, China
Peking University Third Hospital

Beijing, China
The First People's Hospital of Lianyungang

Lianyungang, China
Tianjin Chest Hospital

Tianjin, China
Tianjin Forth Central Hospital

Tianjin, China
Wuxi People's Hospital

Wuxi, China
Xuzhou cancer hospital

Xuzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.